MyFinsight
Home
About
Contact
Back
Income Statement
Avalo Therapeutics, Inc. (AVTX)
source: myfinsight.com
Download
Download image
Comprehensive (loss) income
-$20,799K
Net (loss) income
-$20,765K
(-121.09%↓ Y/Y)
Unrealized loss on
investments, net
-$34K
(loss) income before
taxes
-$20,749K
(-121.07%↓ Y/Y)
Income tax expense
$16K
(128.57%↑ Y/Y)
Total other (expense)
income, net
-$1,433K
(-101.33%↓ Y/Y)
Loss from operations
-$19,316K
(-101.73%↓ Y/Y)
Interest income, net
$1,102K
(6.06%↑ Y/Y)
Change in fair value of
derivative liability
$2,530K
Total operating
expenses
$19,316K
(101.73%↑ Y/Y)
Other expense, net
-$5K
General and
administrative
$5,242K
(15.77%↑ Y/Y)
Research and development
$14,074K
(205.89%↑ Y/Y)
Back